Sonnet BioTherapeutics (SONN) Climbs On Candidate Selection

Sonnet BioTherapeutics SONN Stock News

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) is screaming for the top in the premarket hours this morning, and for good reason. The company said that it has selected a development candidate after completing comparative studies in a mouse melanoma model. Here’s what’s going on: Stop wasting your time! Start finding winning trades in minutes with … Read more